Main Street Research LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 360,526 shares of the exchange traded fund’s stock, valued at approximately $43,959,000. SPDR S&P Biotech ETF comprises approximately 2.5% of Main Street Research LLC’s investment portfolio, making the stock its 17th largest holding.
Other hedge funds have also recently added to or reduced their stakes in the company. Legacy Wealth Managment LLC ID bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $32,000. Ballast Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $36,000. Creative Financial Designs Inc. ADV bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $39,000. Barnes Dennig Private Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $48,000. Finally, Navalign LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth about $48,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock opened at $131.66 on Monday. The business has a 50-day moving average price of $129.82 and a two-hundred day moving average price of $125.16. SPDR S&P Biotech ETF has a 12-month low of $78.00 and a 12-month high of $139.19. The firm has a market cap of $8.40 billion, a P/E ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
